Summary
This state-of-the-art review addresses the clinical management of tricuspid regurgitation in patients with cardiac implantable electronic devices, focusing on the emerging use of percutaneous transcatheter valve replacement and repair. The authors highlight that transvascular lead extraction decisions require multidisciplinary consideration, as extraction may both improve and worsen regurgitation severity, and advocate for including a lead management specialist within the heart team to optimise patient outcomes and minimise procedural complications.
UK applicability
The clinical guidance on multidisciplinary decision-making for CIED lead management in transcatheter valve procedures would be applicable to UK cardiology and electrophysiology services, though specific implementation may depend on local access to lead extraction expertise and interventional capacity.
Key measures
Tricuspid regurgitation severity; lead-valve apparatus interactions; transvascular lead extraction outcomes; jailing complications (lead fracture, infection risk)
Outcomes reported
The review discusses management strategies and clinical decision-making for patients with cardiac implantable electronic devices (CIEDs) and tricuspid regurgitation undergoing percutaneous tricuspid valve intervention. It examines the role of transvascular lead extraction in modifying tricuspid regurgitation severity and reducing procedural risks.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.